130 related articles for article (PubMed ID: 25408147)
1. Association of secreted frizzled-related protein 4 (SFRP4) with type 2 diabetes in patients with stable coronary artery disease.
Hoffmann MM; Werner C; Böhm M; Laufs U; Winkler K
Cardiovasc Diabetol; 2014 Nov; 13():155. PubMed ID: 25408147
[TBL] [Abstract][Full Text] [Related]
2. Human epicardial adipose tissue-derived and circulating secreted frizzled-related protein 4 (SFRP4) levels are increased in patients with coronary artery disease.
Ji Q; Zhang J; Du Y; Zhu E; Wang Z; Que B; Miao H; Shi S; Qin X; Zhao Y; Zhou Y; Huang F; Nie S
Cardiovasc Diabetol; 2017 Oct; 16(1):133. PubMed ID: 29037197
[TBL] [Abstract][Full Text] [Related]
3. Relationship between serum secreted frizzled-related protein 4 levels and the first-phase of glucose-stimulated insulin secretion in individuals with different glucose tolerance.
Liu F; Qu H; Li Y; Tang Q; Yang Z; Wang H; Deng H
Endocr J; 2015; 62(8):733-40. PubMed ID: 26041556
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of fractalkine (FKN) and secreted frizzled-related protein 4 (SFRP-4) serum levels in patients with prediabetes and type 2 diabetes.
Baldane S; Ipekci SH; Ekin A; Abusoglu S; Unlu A; Kebapcilar L
Bratisl Lek Listy; 2018; 119(2):112-115. PubMed ID: 29455547
[TBL] [Abstract][Full Text] [Related]
5. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
6. Role of secreted frizzled-related protein 4 in prediabetes and type 2 diabetes: a cross sectional study.
Sánchez-Pozos K; Granados-Silvestre MA; Nieto-Velázquez NG; Mejía-Blanquel MA; Galicia-Martínez N; Mandujano-Cerón J; Jaimes-Santoyo J; Ortiz-López MG
BMC Endocr Disord; 2024 Jun; 24(1):78. PubMed ID: 38834984
[TBL] [Abstract][Full Text] [Related]
7. Risk prediction with triglycerides in patients with stable coronary disease on statin treatment.
Werner C; Filmer A; Fritsch M; Groenewold S; Gräber S; Böhm M; Laufs U
Clin Res Cardiol; 2014 Dec; 103(12):984-97. PubMed ID: 25012240
[TBL] [Abstract][Full Text] [Related]
8. Secreted frizzled-related protein 4 and its implication in obesity and type-2 diabetes.
Bukhari SA; Yasmin A; Zahoor MA; Mustafa G; Sarfraz I; Rasul A
IUBMB Life; 2019 Nov; 71(11):1701-1710. PubMed ID: 31301214
[TBL] [Abstract][Full Text] [Related]
9. Endothelial function and baroreflex sensitivity according to the oral glucose tolerance test in patients with coronary artery disease and normal fasting glucose levels.
Wykretowicz A; Guzik P; Bartkowiak G; Krauze T; Kasinowski R; Dziarmaga M; Wesseling KH; Wysocki H
Clin Sci (Lond); 2005 Oct; 109(4):397-403. PubMed ID: 15948715
[TBL] [Abstract][Full Text] [Related]
10. Glucose metabolism in non-diabetic patients with stable coronary artery disease.
Santos JF; Almeida M; Ferreira J; Gonçalves P; Raposo L; Teles R; Branco J; Catroga T; Machado FP; Silva A
Rev Port Cardiol; 2006 Jan; 25(1):39-53. PubMed ID: 16623355
[TBL] [Abstract][Full Text] [Related]
11. Secreted Frizzled-Related Protein 4 (SFRP4) is Elevated in Patients with Diabetes Mellitus.
Brix JM; Krzizek EC; Hoebaus C; Ludvik B; Schernthaner G; Schernthaner GH
Horm Metab Res; 2016 May; 48(5):345-8. PubMed ID: 26882051
[TBL] [Abstract][Full Text] [Related]
12. Impact of sitagliptin on carotid intima-media thickness in patients with coronary artery disease and impaired glucose tolerance or mild diabetes mellitus.
Ishikawa S; Shimano M; Watarai M; Koyasu M; Uchikawa T; Ishii H; Inden Y; Takemoto K; Murohara T
Am J Cardiol; 2014 Aug; 114(3):384-8. PubMed ID: 24929624
[TBL] [Abstract][Full Text] [Related]
13. Prorenin and secreted frizzled-related protein 4 levels in women with gestational diabetes mellitus.
Baldane S; Ipekci SH; Kebapcilar AG; Abusoglu A; Beyhekim H; Ilhan TT; Unlu A; Kebapcilar A
Bratisl Lek Listy; 2018; 119(7):450-453. PubMed ID: 30160136
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived miR-103b as a novel biomarker for the early diagnosis of type 2 diabetes.
Luo M; Li R; Deng X; Ren M; Chen N; Zeng M; Yan K; Xia J; Liu F; Ma W; Yang Y; Wan Q; Wu J
Acta Diabetol; 2015 Oct; 52(5):943-9. PubMed ID: 25820527
[TBL] [Abstract][Full Text] [Related]
15. Loss of SFRP4 Alters Body Size, Food Intake, and Energy Expenditure in Diet-Induced Obese Male Mice.
Mastaitis J; Eckersdorff M; Min S; Xin Y; Cavino K; Aglione J; Okamoto H; Na E; Stitt T; Dominguez MG; Schmahl JP; Lin C; Gale NW; Valenzuela DM; Murphy AJ; Yancopoulos GD; Gromada J
Endocrinology; 2015 Dec; 156(12):4502-10. PubMed ID: 26406932
[TBL] [Abstract][Full Text] [Related]
16. Fasting plasma glucose predicts survival and angiographic progression in high-risk postmenopausal women with coronary artery disease.
Vaidya D; Kelemen MD; Bittner V; Tardif JC; Thompson P; Ouyang P
J Womens Health (Larchmt); 2007 Mar; 16(2):228-34. PubMed ID: 17388739
[TBL] [Abstract][Full Text] [Related]
17. Angiographic evaluation of the effects of glucose metabolic status on progression of coronary artery lesions in patients with coronary artery disease.
Wang H; Tang Z; Li X; Hu B; Feng B
J Diabetes; 2014 Nov; 6(6):541-6. PubMed ID: 24981702
[TBL] [Abstract][Full Text] [Related]
18. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
Jaumdally RJ; Lip GY; Patel JV; MacFadyen RJ; Varma C
J Intern Med; 2009 Jun; 265(6):689-97. PubMed ID: 19226374
[TBL] [Abstract][Full Text] [Related]
19. High serum fasting peptide YY (3-36) is associated with obesity-associated insulin resistance and type 2 diabetes.
Ukkola OH; Puurunen VP; Piira OP; Niva JT; Lepojärvi ES; Tulppo MP; Huikuri HV
Regul Pept; 2011 Oct; 170(1-3):38-42. PubMed ID: 21635925
[TBL] [Abstract][Full Text] [Related]
20. Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes.
Mahdi T; Hänzelmann S; Salehi A; Muhammed SJ; Reinbothe TM; Tang Y; Axelsson AS; Zhou Y; Jing X; Almgren P; Krus U; Taneera J; Blom AM; Lyssenko V; Esguerra JL; Hansson O; Eliasson L; Derry J; Zhang E; Wollheim CB; Groop L; Renström E; Rosengren AH
Cell Metab; 2012 Nov; 16(5):625-33. PubMed ID: 23140642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
